Table 1.
Population | |||||
---|---|---|---|---|---|
Domain | Non-caregiver adults with OI | Caregiver adults with OIa, b | Caregivers without OIa | Adolescents with OI | Relatives |
Participation criteria | ≥ 18 years of age |
≥ 18 years of age OI Self-describes as someone who provides care for individuals with OI |
≥ 18 years of age Self-describes as someone who provides care for individuals with OI |
≥ 12–17 years of age OI |
≥ 12 years of age Self-assesses relationship to person with OI as close but does not self-describe as a caregiver |
N questionsc | 37–84 | 50–111 | 49–94 | 28–69 | 10–12 |
Clinical characteristics | Demographic data; for each person with OI: height, OI type, OI severity, causative gene, mobility status | Demographics | |||
Clinical signs, symptoms and events | Signs, symptoms and events in past 12 months and lifetime | NA | |||
Treatment and care experience | Diagnostic pathway, experience with healthcare providers, access to care | NA | |||
QoL | Impact of OI on individuals(s) with OI, impact of signs, symptoms and events, worries | NA | |||
Impact on families | NA | Impact on caregivers and impact on family life | NA | Impact of OI, worries | |
Healthcare consumption | Use of therapies in past 12 months and lifetime, use of inpatient and outpatient care, consumable use | NA | |||
Financial sources for treatment | Insurance coverage, out of pocket spending | NA | NA |
NA, not applicable; OI, osteogenesis imperfecta; QoL, quality of life
aCaregivers provided information on 1–3 care recipients with OI of any age; bCaregivers with OI only provided information about their OI and their experience of caring for individuals with OI, they did not report about the OI experience of individuals in their care; cThe minimum includes compulsory questions without any follow-up questions that only applied to subgroups, the maximum includes all compulsory and optional questions